Leuprolide
- 1 lab in 1 country
- Human trial1
Outcomes
1Coronary total plaque volume
upin humans1
1 study
Coronary total plaque volume
upin humans1
Leuprolide increases coronary total plaque volume in humans (+117.9 mm3, 95% CI 53.3-182.4, P<0.001).
“When compared to the no ADT arm, leuprolide treatment in statin non-users was associated with significantly increased mean-adjusted 1-year ΔTPV (+117.9 mm 3 , 95% CI 53.3-182.4, P<0.001)”
Human trialin statin non-users compared to no ADTcoronary artery12 monthsmales
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
Statin Use Mitigates Androgen Deprivation Therapy-Associated Coronary Atherosclerosis in Prostate Cancer: A Secondary Analysis of the REVELUTION Randomized Clinical Trial
Randomised trial in 90 peopleStatins